Driscoll Michael Joseph 4

What Happened
Michael Joseph Driscoll, a director of Organogenesis Holdings, acquired 10,000 shares in an open-market purchase on 2026-03-09 at $2.67 per share, for a reported total of $26,688. This was a straight purchase (transaction code P), which investors often view as a more informative signal than routine sales—though no motivation should be assumed.

Key Details

• Transaction date: 2026-03-09; Filing date: 2026-03-11 (Form 4 filed within the normal 2-business-day window).
• Price and amount: 10,000 shares at $2.67 per share; total reported cost $26,688.
• Transaction type/code: Open-market purchase (P).
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Footnotes/plans: No 10b5-1 plan, tax withholding, or other footnotes were disclosed in the provided information.

Context
Purchases by directors can be interpreted by some investors as a sign of confidence, but they are not definitive proof of future performance. This filing appears timely and routine; there is no indication here of option exercises, gifts, or other derivative transactions.